SureTrader Advertisement PRTC
Home > Boards > US Listed > Biotechs >

Benitec Biopharma Ltd. ADR (BNTC)

BNTC RSS Feed
Add BNTC Price Alert      Hide Sticky   Hide Intro
Moderator: Blane
Search This Board:
Last Post: 5/24/2016 10:00:11 PM - Followers: 42 - Board type: Free - Posts Today: 0
Silencing Genes For Life™
 




ASX:BLT
NASDAQ: BNTC
                                                                                                                                                    

HOME PAGE
 
 
 
 
 
 
ddRNAi: expressed RNA interference technology
ddRNAi (DNA-directed RNAi) is a unique platform technology for silencing unwanted or disease-causing genes. In the context of therapy, ddRNAi avoids many of the drawbacks of other gene silencing technologies and produces much longer-lasting effects. Benitec Biopharma pioneered ddRNAi and was the first company to demonstrate expressed RNAi in human cells. We hold a dominant intellectual property position in RNAi, with over 40 issued global patents for the human use of ddRNAi. Learn how ddRNAi could target countless human and viral genes. Track our pipeline programs using this exciting technology. View the scope of our patents in ddRNAi. Join us in developing transformational solutions for human health.

Pipeline for ddRNAi gene silencing

Benitec Biopharma’s pipeline of in-house and partnered programs to develop therapeutics for chronic and life-threatening conditions is based on our proprietary technology, DNA-directed RNA(ddRNAi). View our out-licensed programs  

Due to its demonstrated ability to effect long-lasting gene silencing, once proven in human trials, ddRNAi technology has significant potential to treat or cure a broad range of human diseases and conditions. These include cancers, neurological diseases, infectious diseases, autoimmune diseases, genetic diseases and other afflictions that are associated with the expression of a small number of key genes.



Our in-house pipeline is summarized below,  In-house pipeline

. View our out-licensed programs  Out-licensed programs Successful development of therapeutic products in just one of these programs would be a major breakthrough in medical therapy.

 

 

Expressed RNAi for lasting treatment or cure

Tacere Therapeutics develops human therapeutics based on RNA interference (RNAi)  and ddRNAi gene-silencing technology from Benitec Biopharma. Using this approach, the drugs we create promise long term treatment or cure with a single dose.

We target human diseases for which there is currently no effective treatment.  Our pipeline includes drugs for Hepatitis C and Age-Related Macular Degeneration.

Tacere Therapeutics is a Benitec Biopharma company.


http://www.tacerebio.com/index.htm
 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BNTC
Current Price
Volume:
Bid Ask Day's Range
SureTrader
BNTC News: Benitec Biopharma to Host Corporate Update Conference Call 05/17/2016 05:00:00 AM
BNTC News: Report of Foreign Issuer (6-k) 04/29/2016 06:39:47 AM
BNTC News: Benitec to present at the ASGCT 2016 Annual Meeting 04/25/2016 08:30:00 AM
BNTC News: Notice of Effectiveness (effect) 04/20/2016 06:01:43 AM
BNTC News: Benitec's Hepatitis B Therapy Reduces HBV DNA by 98.5% In Vivo 03/08/2016 08:16:00 AM
PostSubject
#2015  Sticky Note Benitec Due Diligence – March 1, 2016 Blane 03/01/16 02:44:27 PM
#2021   The latest as of Tuesday, May 24, 2016 georgejjl 05/24/16 10:00:11 PM
#2020   Benitec to host LIVE corporate conference call on Blane 05/17/16 05:48:54 AM
#2019   Benitec releases impressive OPMD in-vivo data! http://www.benitec.com/documents/ Blane 04/19/16 12:58:30 AM
#2018   Attention all BNTC shareholders, a poster on the Blane 03/27/16 08:26:49 PM
#2017   It is a complete disaster and will survive Analogman 03/09/16 11:31:07 AM
#2016   Benitec releases positive in-vivo HBV data. http://blt.live.irmau.com/IRM/PDF/16 Blane 03/08/16 03:55:24 PM
#2015   Benitec Due Diligence – March 1, 2016 Blane 03/01/16 02:44:27 PM
#2014   Seems so. But at least all the Blane 02/25/16 07:03:14 PM
#2013   The demise of TT-034 was a foregone conclusion: DewDiligence 02/25/16 07:01:29 PM
#2012   HCV trial stopped to pursue other indications. HCV Blane 02/25/16 06:38:49 PM
#2011   Despite where the company is at the moment, Blane 02/11/16 12:28:06 PM
#2010   General Electric is interested in Calimmune georgejjl 01/10/16 03:52:26 PM
#2009   Panno speaks on what data and a new Blane 01/04/16 09:50:38 AM
#2008   $BNTC recent news/filings stocktrademan 12/17/15 03:40:44 PM
#2007   I must apologize. It reads Tues/Wed. So on Blane 12/12/15 04:35:00 PM
#2006   I must apologize. It reads Tues/Wed. Blane 12/12/15 04:31:49 PM
#2005   If you're in the US, yes, it is Blane 12/12/15 03:47:05 PM
#2004   Well, to be frank, there's actually no clear Blane 12/12/15 03:16:58 PM
#2003   Why was the CEO pushed out? DewDiligence 12/09/15 08:31:58 PM
#2002   Benitec announces positive HBV preclinical data! http://blt.live.irmau.com/IRM/P Blane 12/07/15 01:40:33 AM
#2001   Panno speaks on being a Bwnitec investor at Blane 12/06/15 03:21:53 AM
#2000   CSIRO maintains European patents on shrna! Blane 11/21/15 09:46:57 AM
#1999   AASLD Meeting poster located here http://www.benitec.com/documents/presentation/ Blane 11/16/15 10:35:33 AM
#1998   Could the HCV Drug Sofosbuvir Be Cardiotoxic? Blane 11/04/15 07:58:55 PM
#1997   David Suhy gives update presentation at Bio Investor Blane 11/04/15 01:41:50 AM
#1996   Carl Stubbings gives presentation! https://content.knowledgevision.com/player/m Blane 10/28/15 08:23:15 PM
#1995   Interview with Peter French with Bell Direct. https://youtu.be/ksPzRlYT_iw Blane 10/27/15 09:33:35 PM
#1994   Voting Proxy forms thanks to Aido on Hotcopper Blane 10/27/15 05:37:27 PM
#1993   Transcription of Finance News Network with Benitec Biopharma Blane 10/26/15 03:23:26 AM
#1992   For those interested, here's the source of Aussie Minding 10/22/15 11:48:04 AM
#1991   No worries dude! As a moderator, I Blane 10/22/15 04:59:23 AM
#1990   BLT.ax +.12 to A$.56 Bobwins 10/22/15 02:22:49 AM
#1989   Thanks Blane. Been awhile since I have SmokeyNYY 10/22/15 02:00:07 AM
#1988   Panno's newest blog. Enjoy! http://seekingalpha.com/instablog/19837781-pannobhaso/4471626-ttminus- Blane 10/22/15 01:16:01 AM
#1987   Nature Journal discussing shrna role in HBV treatment. Blane 10/21/15 04:59:04 PM
#1986   Results: To date, seven subjects have received a Blane 10/21/15 02:37:14 AM
#1985   Pann speaks on Management Options and Advisory Board. http://seekingalpha.com/in Blane 10/19/15 12:11:09 PM
#1984   Benitec in the news courtesy of Crikeybob On Blane 10/17/15 09:54:08 AM
#1983   Sorry, my first paragraph, last sentence should say Blane 10/10/15 02:51:45 PM
#1982   Firstly, I greatly appreciate your candor. There is Blane 10/10/15 02:26:41 PM
#1981   Preface: Blane, I personally appreciate the compassion and ddRNAi2014 10/09/15 09:02:57 AM
#1980   Peter French interview regarding Nasdaq Bell http://mobile.abc.net.au/news/2015- Blane 10/09/15 07:36:36 AM
#1979   Benitec enters into Lonza agreement for large scale Blane 10/07/15 01:40:35 AM
#1978   The new and improved Calimmune website with new information georgejjl 10/04/15 10:12:40 PM
#1977   Thanks Bellweather! Blane 10/01/15 06:19:08 PM
#1976   Peter French on Arrowhead's Hepatitis B Results(in case bellweather1 10/01/15 08:51:27 AM
#1975   http://www.brw.com.au/p/entrepreneurs/the_balmain_biotech_with_shots_at_xl2cmho5M8Q0IGSAyfSdbI Gr Blane 09/30/15 09:51:00 AM
#1974   "As of September, 2015 we have dosed seven Blane 09/27/15 12:34:12 PM
#1973   Look for the stock ... yup ... to Minding 09/24/15 10:28:16 AM
#1972   Making noise. Minding 09/24/15 10:26:35 AM
PostSubject